title: Clarithromycin-induced akathisia: a class effect of macrolides?
abstract: Clarithromycin is an antibiotic of the macrolide family, which is commonly used in the treatment of respiratory tract infections. We report a woman aged 77 years with bronchiectasis who was prescribed oral clarithromycin for lower respiratory tract infection. She developed akathisia after 2 doses. On withdrawing the antibiotic, her symptoms resolved rapidly after 7 days.
authors.affiliation: Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
authors.forename: Ivie Imasuen
authors.initials: II
authors.lastname: Gbinigie
authors.affiliation: Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK.
authors.forename: Daniel
authors.initials: D
authors.lastname: Lasserson
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D017291:Clarithromycin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D018942:Macrolides / Q000009:adverse effects / Q000627:therapeutic use; D011595:Psychomotor Agitation / Q000209:etiology*; D012141:Respiratory Tract Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D017291:Clarithromycin